Form 4: Bristol-Myers Squibb Director Closes Covered Call Option Position
SEC Form 4 Filing
Director Michael R. McMullen's family trust closed a covered call option position on Bristol-Myers Squibb shares.
Summary
- On July 29, 2024, Michael R. McMullen's family trust closed a covered call option position by purchasing five identical call options.
- The call options were originally written on June 24, 2024, and set to expire on August 16, 2024.
- The options related to 500 shares of Bristol-Myers Squibb common stock.
- The purchase price to close the position was $3.85 per underlying share.
- McMullen is a director of Bristol-Myers Squibb, and the shares are held in a family trust where he is the trustee and a beneficiary.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of a director's transaction in company stock, providing transparency to investors.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it involves a relatively small number of shares and is a personal financial decision of the director.
Key Dates
| Date | Description |
|---|---|
| 06/24/2024 | Family trust wrote five covered call options. |
| 07/29/2024 | Family trust cancelled call options by purchasing five identical call options. |
| 07/31/2024 | Date of signature of the report. |
| 08/16/2024 | Expiration date of the original call options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.